By Robert Preidt HealthDay Reporter HealthDay Reporter MONDAY, May 16, 2022 (HealthDay News) — As the United States mourns one million deaths from COVID-19, a new study indicates the grim tally could have been worse. Use of the Pfizer-BioNTech COVID-19 vaccine prevented more than 110,000 deaths and … Read more
During the study period, 197,535 patients were infected with SARS-CoV-2, and of those 15,786 were admitted to the hospital. A third dose of the Pfizer COVID-19 vaccine conferred higher effectiveness against infection and hospitalisation than two doses of the preventive after one month, a study has found. The study, published in The Lancet Regional Health-Americas, … Read more
COVID-19 vaccine makers have been updating their shots to better match omicron in case global health authorities decide the change is needed. Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday. COVID-19 vaccine … Read more
[MUSIC PLAYING] SPEAKER: How does a COVID-19 mRNA vaccine work? COVID vaccines are now available. Some of the COVID-19 vaccines are mRNA vaccines, but what does this mean? mRNA vaccines are different from traditional vaccines. mRNA vaccines don’t expose you to any real virus instead, they’re made with messenger Ribonucleic Acid or mRNA. This is … Read more
Pfizer: “Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years.” Business Wire: “Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age.” MSNBC: “Fauci reacts to Pfizer news: We hopefully will be … Read more
Margaret Keenan, a 90-year-old grandmother, on Tuesday became the first person in the world to receive the Pfizer COVID-19 vaccine shot outside of a trial as Britain began vaccinating its population. An early riser, Keenan received the vaccine at her local hospital in Coventry, central England, on Tuesday morning at 0631 GMT, a week before … Read more
Pfizer-BioNTech started the Phase 3 clinical trial of BNT162b2 on July 27. (Reuters image) Coronavirus Pfizer-BioNTech vaccine update: In the much-awaited announcement, Pfizer has unveiled Phase 3 human trial final efficacy analysis of BNT162b2 Covid-19 vaccine. It has said the mRNA-based Coronavirus vaccine, jointly developed by US drugmaker Pfizer and German pharma giant BioNTech, has … Read more
Coronavirus Covid-19 vaccine update: Oxford-AstraZeneca said that the late-stage date of their Covid-19 vaccine candidate AZD1222-ChAdOx1nCoV-19 would likely to be announced in November or December. (Reuters image) Coronavirus Covid-19 vaccine update: It could be merry Christmas and a happy new year as Pfizer and BioNTech are preparing to start deliveries of their Covid-19 vaccine candidate … Read more